No Data
No Data
Hong Kong bullish stocks this week | 80% increase in the month! TCL Electronics surged more than 16% this week; CRRC surged nearly 11% the day after
Benefiting from the acceleration of nuclear power approval, CGN's stock price has been rising for five consecutive days; coal supply and demand continued to be tight, and Mongolian coking coal increased by more than 11% during the week.
Direct impact of changes | CRO concept stocks continue to decline, the Federal Reserve does not rule out the possibility of interest rate hikes, and domestic innovative drugs are still in an adjustment cycle
On April 19, $Pharmaceutical Outsourcing Concept (BK1261.HK) $ continued its decline. As of press release, $Kingsley Biotech (01548.HK) $ fell 8.55% to HK$10.48; $Tiger Pharmaceuticals (03347.HK) $ fell 5.87% to HK$29.1; $Kanglong Chemical (03759.HK) $ fell 5.62% to HK$8.40. Market source: Futubull Niu News reported that overnight, Federal Reserve officials made hawkish remarks. New York Federal Reserve Chairman Williams said that if the data reminds us that we need to raise interest rates to achieve our goals, then we will show
Hong Kong Stock Afternoon Review | The three major indices fell sharply, auto stocks fell, and Ideal Auto fell by more than 7%
Technology and network stocks generally fell; Xiaomi fell more than 4%, Meituan fell nearly 4%; shipping stocks rose higher, Pacific Shipping rose more than 9%, and COSCO Haineng rose more than 5%.
Changes in Hong Kong stocks | CRO concept stocks continue to decline, the Federal Reserve does not rule out possible interest rate hikes, domestic innovative drugs are still in an adjustment cycle
CRO concept stocks continued to decline. As of press release, Tiger Pharmaceuticals (03347.HK) fell 7.94% to HK$28.4; Kingsley Biotech (01548.HK) fell 5.93% to HK$10.78; Kanglong Chemical (03759.HK) fell 4.83% to HK$8.47; and Pharmaceuticals (02359.HK) fell 4.5% to HK$32.9.
Selected announcements | China Electric Power's Q1 electricity sales increased by more than 30%; China Coal Energy's Q1 commercial coal sales fell by about 15%
Xinhua Insurance: Q1 received an 11.7% year-on-year decrease in total premium income; Meituan spent about HK$399 million to repurchase 4 million shares.
Kingsley Biotechnology (01548.HK): CARVYKTI's net trade sales in the first quarter were about US$157 million
On April 16, 2024, Legend Biotech Co., Ltd. (LEGENDARY BIOTECH) announced that in accordance with the cooperation and licensing agreement signed by Legend Biotech, Inc. (Janssen) on December 21, 2017, CARVYKTI generated net trade sales of approximately US$157 million in the quarter ending March 31, 2024.
No Data